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Figure 1. A. An eccentric, lipid rich plaque with evidence of necrotic core and an overlying 40 µm thick fibrous cap at
2 o’clock and calcific deposits at 11–12 o’clock (image from M3 optical coherence tomography model); B. Un-
changed plaque morphology at 15 months follow-up (image from C7 optical coherence tomography model);
C, D. Magnification of the “A” and “B” images.
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Plaque rupture with subsequent formation of
occlusive thrombus accounts for about 70% of cas-
es of acute coronary syndrome (ACS). Plaques cha-
racterized by a thin fibrous cap (< 65 µm) overlying
a large lipid rich necrotic core have been associat-
ed with ACS in in-vivo and post-mortem studies and
referred to as thin-cap fibroatheroma (TCFA) [1].
As a less prevalent finding, TCFA has also been
identified in non-culprit arteries of ACS patients and
in stable angina patients [2]. There is limited infor-
mation about the natural history of this phenomenon.
Neither conventional angiography nor intravascular
ultrasound have sufficient resolution to detect TCFA.
Optical coherence tomography (OCT), with its near-
microscopic resolution, is able to detect TCFA and
offers detailed insight into its morphology.
We present a patient with non-insulin depend-
ent diabetes mellitus and stable angina pectoris
where OCT detected TCFA in the left circumflex
artery during the initial OCT examination (Fig. 1A),
nine months after drug eluting stent implantation
in a more distal segment. Total cholesterol was
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3.7 mMol/L under treatment with 40 mg of atorvas-
tatin. Repeat OCT images 15 months later showed
no changes in fibrous cap thickness or lipidic plaque
morphology in corresponding cross-sections (Fig. 1B).
These images suggest that TCFA can remain sta-
ble over time under good pharmacological control
of risk factors including cholesterol.
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